Bausch + Lomb Stock Forecast
NYSE: BLCOHealth CareOphthalmic GoodsUSD
Market open · Delayed 15 min · as of Oct 8, 1:25 PM ET
BLCO analyst consensus
Consensus (15 analysts)
buy
Avg. price target
$19.39+12.67%
- Strong buy 2
- Buy 5
- Hold 7
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 15 Wall Street analysts covering Bausch + Lomb (2026-10-08), 7 rate the stock a buy or strong buy, 7 rate it a hold and 1 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $19.39, with a high estimate of $24.00 and a low estimate of $16.00. The average target implies upside of 12.7% from the current price of $17.21.
The spread between the highest and lowest targets is 50.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BLCO.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 2 | 13% |
| Buy | 5 | 33% |
| Hold | 7 | 47% |
| Sell | 0 | 0% |
| Strong sell | 1 | 7% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $16.00 | -7.03% |
| Average target | $19.39 | +12.67% |
| High target | $24.00 | +39.45% |